
Advertisement
February 24, 2012 | 1:22 pm
Posted by Albert Fuchs, M.D.

Photo by Wikipedia/CDC/Joe Millar
Our old nemesis, the clap, is in the news again this month.
Gonorrhea is the second most common sexually transmitted disease in the US, with more than 600,000 cases annually. In men it usually causes pain on urination, penile discharge, or sore throat. In women it may not cause symptoms or may cause painful urination, vaginal discharge, or sore throat. If untreated, gonorrhea can spread to the fallopian tubes, joints, and heart valves. I know that most readers simply can’t hear enough about penile discharge (especially if they’re reading this over lunch), I’ve included a microscopic image of exactly that. The gonorrhea bacteria are visible as the small dark dots.
With the discovery of penicillin in the 1940s the treatment of gonorrhea was revolutionized. But ever since that major victory gonorrhea has won several important battles. Gonorrhea developed resistance to sulfanilamide in the 1940s and to penicillins and tetracyclines in the 1980s. When I trained in internal medicine in the mid 1990s, Cipro (an antibiotic in the family called fluoroquinolones) was the preferred treatment for gonorrhea. In the 2000s some fluoroquinolone-resistant strains of gonorrhea appeared and by 2007 resistance was widespread.
Third generation cephalosporins are now the last antibiotic family to which gonorrhea is susceptible. But, as a decade ago with fluoroquinolones, sensitivity to cephalosporins is slowly decreasing, especially in the western US. Though no strain in the US has become resistant yet, a strain isolated from a patient in Japan in 2009 was highly resistant to cephalosporins.
The downward creeping cephalosporin sensitivity of gonorrhea prompted CDC researchers to sound the alarm in an editorial in the New England Journal of Medicine earlier this month. The editorial warns that if the early signs of decreasing sensitivity are analogous to what we observed with fluoroquinolones in the ‘90s, then we may be only a few years away from strains of gonorrhea that are untreatable by any antibiotics.
The authors make sound recommendations to accelerate development of new antibiotics and increase surveillance of gonorrhea antibiotic sensitivity. But it’s entirely possible that these efforts will fail, and that the only defense against gonorrhea will be from a vaccine which is not expected any time soon.
I’ve written before about the emerging problem of bacterial antibiotic resistance. Our grandchildren may study the period from the 1940s to the 2040s as the antibiotic century. Unless antibiotic development stays a step ahead of the wily microorganisms we may reach a time when sexually transmitted infections are managed the way they were a hundred years ago – promoting the use of condoms and corny public health posters encouraging men to keep their flies zipped.
Learn more:
CDC Warns Untreatable Gonorrhea is On the Way (Chicago Tribune)
Gonorrhea Could Join Growing List of Untreatable Diseases (Scientific American)
Antibiotic-Resistant Gonorrhea (Centers for Disease Control and Prevention)
The Emerging Threat of Untreatable Gonococcal Infection (New England Journal of Medicine)
Gonorrhea (U.S. National Library of Medicine)
Important legal mumbo jumbo:
Anything you read on the web should be used to supplement, not replace, your doctor’s advice. Anything that I write is no exception. I’m a doctor, but I’m not your doctor.

5.24.13 at 3:34 pm | Why we know less than we think about the health. . .

5.17.13 at 2:55 pm | Ms. Jolie’s brave revelation might be. . .

5.10.13 at 9:23 am | Number of suicides exceeds deaths in traffic. . .

4.26.13 at 4:53 pm | A bird flu strain gets the attention of public. . .

4.19.13 at 6:48 am | ACP recommendations clarify a murky topic.

4.12.13 at 6:39 pm | A list of tidbits learned at the ACP conference.

2.4.11 at 11:59 am | The FDA recently issued a warning about. . . (1542)

5.17.13 at 2:55 pm | Ms. Jolie’s brave revelation might be. . . (589)

4.26.13 at 4:53 pm | A bird flu strain gets the attention of public. . . (42)
We welcome your feedback.
Your information will not be shared or sold without your consent. Get all the details.
JewishJournal.com has rules for its commenting community.Get all the details.
JewishJournal.com reserves the right to use your comment in our weekly print publication.
health bloghome doctor medicine albert fuchs health care storyblog nicejewishdoctor antibiotics nice jewish doctor virus healthcare skeptic vaccine science vaccination antibiotic resistance weight loss skepticism prostate cancer water cdc health and safety cancer gonorrhea sti health issues h7n9 flu in china necc earthquake overweight urethritis primary care cantaloupe life guard vegetarianism nuts nose flu vaccine health-care
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
| |||||||||